Your browser doesn't support javascript.
loading
The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC.
Dong, Jianming; Zhang, Rongzheng; Xia, Yan; Jiang, Xu; Zhou, Kun; Li, Jiaqi; Guo, Mengrui; Cao, Xinyang; Zhang, Shuyun.
Afiliação
  • Dong J; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang R; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Xia Y; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Jiang X; Department of Parasitology, Harbin Medical University, Harbin, China.
  • Zhou K; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li J; Beidahuang Industry Group General Hospital Department of Clinical Laboratory, Harbin, China.
  • Guo M; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Cao X; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang S; Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Immunol ; 14: 1142319, 2023.
Article em En | MEDLINE | ID: mdl-37180150
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article